Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.

698 F. App'x 1035
CourtCourt of Appeals for the Federal Circuit
DecidedOctober 17, 2017
Docket2017-1033
StatusPublished

This text of 698 F. App'x 1035 (Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc., 698 F. App'x 1035 (Fed. Cir. 2017).

Opinion

JUDGMENT

Per Curiam

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
698 F. App'x 1035, Counsel Stack Legal Research, https://law.counselstack.com/opinion/classen-immunotherapies-inc-v-elan-pharmaceuticals-inc-cafc-2017.